SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
IMMUCOR, INC.
(Name of Issuer)
Common
(Title of Class of Securities)
452526-10-6-10
(CUSIP Number)
Check the following box if a fee is being paid with this statement /_/. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
SCHEDULE 13G
CUSIP No. 452526-10-6-10
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Josef Wilms
2. Check the Appropriate Box if a Member of a Group (a) /_/
(b) /_/
3. SEC Use Only
4. Citizenship or Place of Organization
Federal Republic of Germany
Number of Shares Beneficially Owned By Each Reporting Person With
5. Sole Voting Power
333,000
6. Shared Voting Power
None
7. Sole Dispositive Power
333,000
8. Shared Dispositive Power
None
9. Aggregate Amount Beneficially Owned by Each Reporting Person
333,000
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares /_/
11. Percent of Class Represented by Amount in Row 9
4.04%
12. Type of Reporting Person
IN
Schedule 13G - Amendment No. 1
The undersigned hereby amends the statement on Schedule 13G, dated February 1,
1995, filed by the undersigned, relating to the shares of Common Stock, par
value of $.10 per share of Immucor, Inc., as set forth below.
Item 4. Ownership
(a) Amount Beneficially Owned
Josef Wilms is the beneficial owner of warrants to purchase 243,750
shares of Common Stock at an exercise price of $7.75, and options to
acquire 89,250 shares of Common Stock at an exercise price of $9.33.
(b) Percent of Class
4.04%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 333,000
(ii) sole power to dispose or the direct the disposition of: 333,000
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following box /X/.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 12, 1996
Date
/s/ Josef Wilms
Signature
Josef Wilms, President, Immucor GmbH
Name/Title
EXHIBIT 99 - Restatement of Original Schedule 13G Previously Filed in Paper Form
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __ )
IMMUCOR, INC.
(Name of Issuer)
Common
(Title of Class of Securities)
452526-10-6-10
(CUSIP Number)
Check the following box if a fee is being paid with this statement /X/. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
SCHEDULE 13G
CUSIP No. 452526-10-6-10
1. Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Josef Wilms
2. Check the Appropriate Box if a Member of a Group (a) /_/
(b) /_/
3. SEC Use Only
4. Citizenship or Place of Organization
Federal Republic of Germany
Number of Shares Beneficially Owned By Each Reporting Person With
5. Sole Voting Power
408,000
6. Shared Voting Power
None
7. Sole Dispositive Power
408,000
8. Shared Dispositive Power
None
9. Aggregate Amount Beneficially Owned by Each Reporting Person
408,000
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares /_/
11. Percent of Class Represented by Amount in Row 9
5.0%
12. Type of Reporting Person
IN
Item 1.
(a) Name of Issuer
Immucor, Inc.
(b) Address of Issuer's Principal Executive Offices
3130 Gateway Drive
Post Office Box 5625
Norcross, Georgia 30091-5625
Item 2.
(a) Name of Person Filing
Josef Wilms
(b) Address of Principal Business Office or, if none, Residence
Immucor Medizinische Diagnostik GmbH
Postfach 200247
D-63308 Rodermark
Adam Opel Strasse 26
D-63322 Rodermark
(c) Citizenship
Federal Republic of Germany
(d) Title of Class of Securities
Common Stock
(e) CUSIP Number
Inapplicable
Item 3.
Inapplicable.
Item 4. Ownership
(a) Amount Beneficially Owned
Josef Wilms is the beneficial owner of warrants to purchase 318,750
shares of Common Stock at an exercise price of $7.75, and options to
acquire 89,250 shares of Common Stock at an exercise price of $9.33.
(b) Percent of Class
5.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 408,000
(iii) sole power to dispose or to direct the disposition of: 408,000
Item 5. Ownership of Five Percent or Less of a Class
Inapplicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Inapplicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Inapplicable.
Item 8. Identification and Classification of Members of the Group
Inapplicable.
Item 9. Notice of Dissolution of Group
Inapplicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect
of changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 1, 1995
Date
/s/ Josef Wilms
Signature
Josef Wilms, President
Name/Title
